SCNIScinai Immunotherapeutics Ltd. American Depositary Shares
Identity
- Security key
- 21407
- Ticker
- SCNI
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2015-05-12
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- SCNI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,276,837.6
- Shares outstanding (class)
- 5,169,383
- Shares outstanding (weighted)
- 5,169,383
- SIC
- 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Employees
- 45
- Location
- JERUSALEM, L3
- Homepage
- https://www.scinai.com
- Description
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.